Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPTi Drug Options in Tanzania
NCT00158574Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jan 2005
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mefloquine, chlorproguanil + dapsone in malaria, sponsored by London School of Hygiene & Tropical Medicine. Started Jan 2005; status: completed.
02
Drugs
mefloquinechlorproguanil + dapsone
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00158574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00158574.